Flatley's Law: The Company Speeding A Genetic Revolution

Every time I see articles like this, it reminds me how much the FDA&#x27;s poor treatment of the genetic testing market infuriates me. What the FDA has done to 23andMe is disgusting (an Illumina customer).<p>Why can&#x27;t I spend $99 and find out if I have a prominent heart disease marker, that killed both my father and grandfather by 55? Because the healthcare market is regulated by the government for the benefit of various cartels. They want me to spend thousands of dollars and be forced to go through layers of doctors to get the same results instead.

I&#x27;d make two observations:<p>1) Illumina&#x2F;Solexa&#x27;s breakthrough was to convert sequencing into a problem limited by computing resources (reassembling the jigsaw), so they were able to leverage improvements in semiconductor processing.<p>2) This quote grabbed me:<p>&quot;But Flatley is confident that Illumina’s footprint, which includes not just machines but also the software to handle genomic data, will make the company hard to unseat.&quot;<p>A call to arms for the Free Software movement?